Video_2_Intravital Imaging of Adoptive T-Cell Morphology, Mobility and Trafficking Following Immune Checkpoint Inhibition in a Mouse Melanoma Model.AVI
Efficient T-cell targeting, infiltration and activation within tumors is crucial for successful adoptive T-cell therapy. Intravital microscopy is a powerful tool for the visualization of T-cell behavior within tumors, as well as spatial and temporal heterogeneity in response to immunotherapy. Here we describe an experimental approach for intravital imaging of adoptive T-cell morphology, mobility and trafficking in a skin-flap tumor model, following immune modulation with immune checkpoint inhibitors (ICIs) targeting PD-L1 and CTLA-4. A syngeneic model of ovalbumin and mCherry-expressing amelanotic mouse melanoma was used in conjunction with adoptively transferred OT-1+ cytotoxic T-cells expressing GFP to image antigen-specific live T-cell behavior within the tumor microenvironment. Dynamic image analysis of T-cell motility showed distinct CD8+ T-cell migration patterns and morpho-dynamics within different tumor compartments in response to ICIs: this approach was used to cluster T-cell behavior into four groups based on velocity and meandering index. The results showed that most T-cells within the tumor periphery demonstrated Lévy-like trajectories, consistent with tumor cell searching strategies. T-cells adjacent to tumor cells had reduced velocity and appeared to probe the local environment, consistent with cell-cell interactions. An increased number of T-cells were detected following treatment, traveling at lower mean velocities than controls, and demonstrating reduced displacement consistent with target engagement. Histogram-based analysis of immunofluorescent images from harvested tumors showed that in the ICI-treated mice there was a higher density of CD31+ vessels compared to untreated controls and a greater infiltration of T-cells towards the tumor core, consistent with increased cellular trafficking post-treatment.
History
References
- https://doi.org//10.1126/science.342.6165.1432
- https://doi.org//10.1186/s13046-019-1266-0
- https://doi.org//10.1038/s41591-018-0040-8
- https://doi.org//10.1038/s41419-018-0278-6
- https://doi.org//10.1155/2019/3425291
- https://doi.org//10.1158/0008-5472.CAN-14-2458
- https://doi.org//10.3390/cancers9070092
- https://doi.org//10.3389/fimmu.2018.02593
- https://doi.org//10.1093/annonc/mdx238
- https://doi.org//10.3389/fimmu.2019.00128
- https://doi.org//10.1111/imm.13082
- https://doi.org//10.1126/science.aar4060
- https://doi.org//10.1056/nejmoa1414428
- https://doi.org//10.1056/nejmoa1503093
- https://doi.org//10.1056/NEJMoa1809615
- https://doi.org//10.1016/S1470-2045(18)30144-X
- https://doi.org//10.1038/nrd4591
- https://doi.org//10.1158/1538-7445.SABCS18-CT036
- https://doi.org//10.1038/ncponc0666
- https://doi.org//10.1038/s41434-018-0019-6
- https://doi.org//10.1186/s40425-018-0343-9
- https://doi.org//10.1016/j.it.2019.09.002
- https://doi.org//10.1126/sciimmunol.aaq0491
- https://doi.org//10.7150/thno.37924
- https://doi.org//10.1007/s11307-018-1254-3
- https://doi.org//10.1016/j.biocel.2018.06.008
- https://doi.org//10.1016/j.ccr.2012.01.008
- https://doi.org//10.1016/0092-8674(94)90169-4
- https://doi.org//10.1006/cimm.2001.1895
- https://doi.org//10.1038/nmeth.2075
- https://doi.org//10.1182/blood-2010-08-299438
- https://doi.org//10.1186/s12885-015-1347-1
- https://doi.org//10.1001/jamadermatol.2014.1348
- https://doi.org//10.1016/j.ccell.2014.09.007
- https://doi.org//10.1038/sj.cgt.7700263
- https://doi.org//10.1073/pnas.0500600102
- https://doi.org//10.1084/jem.20180654
- https://doi.org//10.1242/bio.030106
- https://doi.org//10.1016/j.immuni.2008.10.015
- https://doi.org//10.1371/journal.pone.0164247
- https://doi.org//10.1371/journal.ppat.1005881
- https://doi.org//10.3389/fimmu.2018.02737
- https://doi.org//10.1038/nature13954
- https://doi.org//10.1126/scitranslmed.3004394
- https://doi.org//10.7554/eLife.14756
- https://doi.org//10.1371/journal.pone.0206693
- https://doi.org//10.1186/2045-824X-6-17
- https://doi.org//10.1084/jem.20161950
- https://doi.org//10.1158/0008-5472.CAN-15-1707
- https://doi.org//10.1038/nri1056
- https://doi.org//10.4049/jimmunol.171.5.2225
- https://doi.org//10.1038/nri2253
- https://doi.org//10.1016/j.immuni.2018.06.012
- https://doi.org//10.1084/jem.20121416
- https://doi.org//10.1038/s41467-018-06563-w
- https://doi.org//10.1038/nri.2015.16
- https://doi.org//10.1182/blood-2017-06-741033
- https://doi.org//10.1186/1479-5876-11-108
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity